Lechowicz, K.; Drożdżal, S.; Machaj, F.; Rosik, J.; Szostak, B.; Zegan-Barańska, M.; Biernawska, J.; Dabrowski, W.; Rotter, I.; Kotfis, K.
COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection. J. Clin. Med. 2020, 9, 1917.
https://doi.org/10.3390/jcm9061917
AMA Style
Lechowicz K, Drożdżal S, Machaj F, Rosik J, Szostak B, Zegan-Barańska M, Biernawska J, Dabrowski W, Rotter I, Kotfis K.
COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection. Journal of Clinical Medicine. 2020; 9(6):1917.
https://doi.org/10.3390/jcm9061917
Chicago/Turabian Style
Lechowicz, Kacper, Sylwester Drożdżal, Filip Machaj, Jakub Rosik, Bartosz Szostak, Małgorzata Zegan-Barańska, Jowita Biernawska, Wojciech Dabrowski, Iwona Rotter, and Katarzyna Kotfis.
2020. "COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection" Journal of Clinical Medicine 9, no. 6: 1917.
https://doi.org/10.3390/jcm9061917
APA Style
Lechowicz, K., Drożdżal, S., Machaj, F., Rosik, J., Szostak, B., Zegan-Barańska, M., Biernawska, J., Dabrowski, W., Rotter, I., & Kotfis, K.
(2020). COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection. Journal of Clinical Medicine, 9(6), 1917.
https://doi.org/10.3390/jcm9061917